Cardiometabolic Rx: Part 2: Interventions and innovations
About this episode
The episode discusses practical treatment strategies for cardiometabolic dysfunction, focusing on GLP-1 receptor agonists and multidisciplinary approaches.
In part two of our Perspectives podcast, fx Medicine by BioCeuticals ambassadors Lisa Costa-Bir, Dr Michelle Woolhouse, Mick Alexander and Dr Adrian Lopresti, join host Emma Sutherland to explore practical, evidence-aligned treatment strategies for patients with cardiometabolic dysfunction. The discussion covers GLP-1 receptor agonists (GLP-1 RAs) including side effect management and dietary and lifestyle support. They also discuss the evolving landscape of new cardiometabolic medications, and the behavioural, psychological, and social factors that shape long-term cardiometabolic outcomes. The ambassadors break down current evidence, share their clinic insights from their own practice, and examine how practitioners can better support patients through complementary medicine use, behavioural change, and sustained diet and lifestyle modification. A detailed case study illustrates multidisciplinary reasoning across naturopathy, psychology, pharmacy and general practice, highlighting how small, achievable steps can create meaningful momentum for complex patients. This episode gives practitioners a comprehensive and compassionate roadmap for supporting sustainable cardiometabolic…
More episodes of FX Medicine Podcast Central
- The biology of sustainable weight loss with Emma Sutherland and Dr Nick Fuller
- REPLAY: Exercise, training & the influence of female sex hormones with Lisa Costa-Bir & Dr Stacy Sims
- REPLAY: Cardiovascular health in pregnancy and postpartum
- Androgens in women: From excess to sensitivity with Emma Sutherland and Lara Briden
- Continuous glucose monitoring with Dr Michelle Woolhouse and Dr Jessica Turton
- Cardiometabolic Rx: Part 1: Metabolic foundations and myths
Explore listener stats, chart rankings, contacts and more on the FX Medicine Podcast Central podcast page.